Valo Health

News

Merck partners Valo on $3bn, AI-based Parkinson's project

Merck has teamed up with Valo Health on a project to apply AI to the discovery of novel drug targets and drugs for Parkinson's.

Digital

Asking the right questions around AI, with Brian Alexander, ...

At BIO 2025, editor-in-chief Jonah Comstock spoke with Brian Alexander, CEO of Valo Health, about how he’s seeing the AI conversation evolve.

News

Novo Nordisk swells alliance with AI firm Valo Health

Novo Nordisk almost doubles the scale of its R&D alliance with AI specialist Valo Health, which now spans 20 programmes and a value of up to $4.6bn.

News

Valo Health chief executive Brian Alexander, who is also CEO-Partner of Flagship Pioneering

Flagship-backed AI startup Valo shelves eye disease drug

Valo Health will no longer develop its ROCK1/2 inhibitor for diabetic retinopathy on its own after a trial readout but will seek to partner the drug.

News

Valo Health bags $2.7bn AI partnership with Novo Nordisk

Novo Nordisk has paid $60 million to partner Valo Health on a project that will apply the US start-up’s artificial intelligence-powered drug discovery engine to find new t

Merck partners Valo on $3bn, AI-based Parkinson's project

Asking the right questions around AI, with Brian Alexander, ...

Novo Nordisk swells alliance with AI firm Valo Health

Flagship-backed AI startup Valo shelves eye disease drug

Valo Health bags $2.7bn AI partnership with Novo Nordisk

NHS "isn't delivering equitable care for rare diseases"

Using AI-driven synthetic personas to take your insights fur...

Valo Health

Editor's Picks